Spain · Delayed Price · Currency is EUR BME:YSRR Statistics
Total Valuation
BME:YSRR has a market cap or net worth of EUR 98.66 million. The enterprise value is 133.98 million.
| Market Cap | 98.66M |
| Enterprise Value | 133.98M |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:YSRR has 4.98 million shares outstanding.
| Current Share Class | 4.98M |
| Shares Outstanding | 4.98M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.18M |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.74 |
| PB Ratio | 2.23 |
| P/TBV Ratio | 2.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 4,762.05 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -89.84 |
| EV / Sales | 25.45 |
| EV / EBITDA | 92.00 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03, with a Debt / Equity ratio of 0.81.
| Current Ratio | 0.03 |
| Quick Ratio | 0.03 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 24.51 |
| Debt / FCF | n/a |
| Interest Coverage | 0.11 |
Financial Efficiency
Return on equity (ROE) is -3.32% and return on invested capital (ROIC) is 0.23%.
| Return on Equity (ROE) | -3.32% |
| Return on Assets (ROA) | 0.14% |
| Return on Invested Capital (ROIC) | 0.23% |
| Return on Capital Employed (ROCE) | 0.34% |
| Weighted Average Cost of Capital (WACC) | 4.13% |
| Revenue Per Employee | 5.27M |
| Profits Per Employee | -1.49M |
| Employee Count | 1 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.00 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 19.80 |
| 200-Day Moving Average | 19.80 |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:YSRR had revenue of EUR 5.27 million and -1.49 million in losses.
| Revenue | 5.27M |
| Gross Profit | 2.44M |
| Operating Income | 185,217 |
| Pretax Income | -1.49M |
| Net Income | -1.49M |
| EBITDA | 1.46M |
| EBIT | 185,217 |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 365,947 in cash and 35.69 million in debt, with a net cash position of -35.33 million or -7.09 per share.
| Cash & Cash Equivalents | 365,947 |
| Total Debt | 35.69M |
| Net Cash | -35.33M |
| Net Cash Per Share | -7.09 |
| Equity (Book Value) | 44.24M |
| Book Value Per Share | n/a |
| Working Capital | -25.27M |
Cash Flow
| Operating Cash Flow | 20,717 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.27M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 46.33%, with operating and profit margins of 3.52% and -28.32%.
| Gross Margin | 46.33% |
| Operating Margin | 3.52% |
| Pretax Margin | -28.32% |
| Profit Margin | -28.32% |
| EBITDA Margin | 27.66% |
| EBIT Margin | 3.52% |
| FCF Margin | n/a |
Dividends & Yields
BME:YSRR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1.51% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |